Literature DB >> 6958930

Variant cell lines from the human promyelocyte line HL60.

D Toksoz, C M Bunce, P C Stone, R H Michell, G Brown.   

Abstract

The continuous human promyeloid cell line HL60 may be induced to differentiate into neutrophils by the presence of 1.25% dimethylsulphoxide (DMSO) and related compounds [4]. When treated with 12-O-tetradecanoylphorbol-13-acetate (TPA), the cells exhibit may features characteristic of monocytes/macrophages [13]. In both cases, the induced HL60 cells lose their proliferative ability. The availability of this inducible cell line has led to an increasing number of studies aimed at dissecting the process of myeloid differentiation. However, the correct interpretation of such studies may only be reached through the use of appropriate cellular controls; specifically, variant HL60 cell lines which do not differentiate in response to the inducing agents. Here we report the isolation and characterization of two variant cell lines of HL60 which do not differentiate in the presence of 1.25% dimethylsulphoxide but still respond to TPA. Comparison of these HL60 variants with the parental line should facilitate the elucidation of molecular events which regulate myeloid differentiation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6958930     DOI: 10.1016/0145-2126(82)90006-6

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.

Authors:  Caroline Palmeira dos Santos; Gustavo J S Pereira; Christiano M V Barbosa; Aron Jurkiewicz; Soraya S Smaili; Claudia Bincoletto
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

2.  Near neighbour analysis of variant cell lines derived from the promyeloid cell line HL60.

Authors:  C M Bunce; J M Lord; A K Wong; G Brown
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

3.  Sequential determination of lineage potentials during haemopoiesis.

Authors:  G Brown; C M Bunce; G R Guy
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.